Description
IGF::OT::IGF CPRR COAGULATION TESTING
First action · last action
2014-10-01 · 2019-06-24
Transactions
10
First transaction's obligation
$135,749
Base + all options value (sum of deltas)
$487,423
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30108
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 10 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$135,749= $135,749
- Mod P000012015-07-16+$138,744= $274,493
- Mod P000022015-09-02-$138,744= $135,749
- Mod P000032015-09-25+$2,000= $137,749
- Mod P000042015-10-01+$138,744= $276,493
- Mod P000052016-01-22-$13,480= $263,013
- Mod P000062016-10-01+$138,840= $401,853
- Mod P000072016-12-23-$13,154= $388,700
- Mod P000082017-09-22+$138,840= $527,540
- Mod P000132019-06-24-$40,117= $487,423
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$135,749 | $135,749 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00001· EXERCISE AN OPTION | 2015-07-16 | +$138,744 | $274,493 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00002· FUNDING ONLY ACTION | 2015-09-02 | −$138,744 | $135,749 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00003· FUNDING ONLY ACTION | 2015-09-25 | +$2,000 | $137,749 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00004· EXERCISE AN OPTION | 2015-10-01 | +$138,744 | $276,493 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00005· CLOSE OUT | 2016-01-22 | −$13,480 | $263,013 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00006· EXERCISE AN OPTION | 2016-10-01 | +$138,840 | $401,853 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00007· CLOSE OUT | 2016-12-23 | −$13,154 | $388,700 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00008· EXERCISE AN OPTION | 2017-09-22 | +$138,840 | $527,540 | IGF::OT::IGF CPRR COAGULATION TESTING |
| Mod P00013· FUNDING ONLY ACTION | 2019-06-24 | −$40,117 | $487,423 | IGF::OT::IGF CPRR COAGULATION TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JA87HT8KP2M2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0379 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $671,956 | FY2026 |
| 36C25626P0989 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $24,200 | FY2026 |
| 36C24126N0746 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,961 | FY2026 |
| 36C24126N0753 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $89,895 | FY2026 |
| 36C24126N0747 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $127,637 | FY2026 |
| 36C24126N0748 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,031 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0684 | VERACYTE, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,730 | FY2026 |
| 36C24826P0831 | UNIVERSITY OF MIAMI | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $178,265 | FY2026 |
| 36C24826N0548 | D & D LABORATORY LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $14,915 | FY2026 |
| 36C24826P0651 | ROCHE DIAGNOSTICS CORPORATION | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $239,858 | FY2026 |
| 36C24826P0221 | REPROSOURCE FERTILITY DIAGNOSTICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $27,500 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24814F4123_3600_V797D30108_3600 · retrieved 2026-09-26.